Merck KGAA (PK) Stock Quote MKGAF - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

183.935

Bid

183.00

Ask

192.35

Volume

183.935 Day's Range 191.415

143.463 52 Week Range 264.40

Market Cap

23.772B

Previous Close

184.721

Open

191.415

Last Trade

183.935

Last Trade Time

12:52:37

Financial Volume

$ 5,705

VWAP

190.1683

Average Volume (3m)

444

Shares Outstanding

129,242,251

Dividend Yield

1.08%

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

20.99B

Net Profit

2.82B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.merck.de

Headquarters

Darmstadt, Deu

Founded

1987

Merck KGAA (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker MKGAF. The last closing price for Merck KGAA (PK) was $184.72. Over the last year, Merck KGAA (PK) shares have traded in a share price range of $ 143.463 to $ 264.40.

Merck KGAA (PK) currently has 129,242,251 shares outstanding. The market capitalization of Merck KGAA (PK) is $23.87 billion.

Data on Merck KGaA's L-BLP25 - Analyst Blog

Merck KGaA (MKGAF ) recently presented detailed results on its oncology candidate L-BLP25, from the phase III study, START (Stimulating Targeted Antigenic Responses To NSCLC). Results...

Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog

Merck KGaA (MKGAF) reported first quarter 2013 earnings per American Depositary Receipt (ADR) of $2.79, up 28.1% year over year. Revenues for the reported quarter were up 4.4% year over year...

Merck KGaA-CBRX Renew Agreement - Analyst Blog

Merck KGaA (MKGAF) and Columbia Laboratories, Inc. (CBRX) recently renewed a license and supply agreement for Crinone (progesterone gel), extending it for an additional five years. This...

Sanofi Reports Lemtrada Data - Analyst Blog

Sanofi’s (SNY) subsidiary, Genzyme, recently announced interim data on its multiple sclerosis (MS) candidate, Lemtrada (alemtuzumab), from the first year of an extension study. ...

Merck KGaA-BMY Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a deal with Bristol-Myers Squibb (BMY) for the promotion of different formulations of Glucophage (metformin hydrochloride) in China. Glucophage is used for...

Merck KGaA - Nordic Bioscience Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a strategic deal with Nordic Bioscience Clinical Development A/S for its pipeline candidate, sprifermin (recombinant human FGF-18). Sprifermin is being...

Threshold Cuts Loss, Misses Sales - Analyst Blog

Threshold Pharmaceuticals Inc. (THLD) reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss of 11...

Strong Quarter for Merck KGaA - Analyst Blog

Merck KGaA (MKGAF) reported fourth quarter 2012 earnings per American Depository Receipt (ADR) of $2.66, up 18.8% year over year. Revenues for the reported quarter were up 8% year over year...

Positive Data from BMRN's PKU-016 - Analyst Blog

BioMarin Pharmaceutical Inc. (BMRN) recently announced positive results from the PKU-016 ASCEND study. This is the largest randomized controlled study evaluating the safety and therapeutic...

Threshold/Merck KGaA Drug in Study - Analyst Blog

Threshold Pharmaceuticals, Inc. (THLD) and Merck KGaA (MKGAF) recently announced the commencement of a global phase III study (MAESTRO) on their hypoxia-targeted candidate, TH-302. The study...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-5.855	-3.08498867169	189.79	200.56	183.88	154	190.46145123	CS
4	9.585	5.49756237453	174.35	200.56	156.75	218	176.06775216	CS
12	8.213	4.6738598468	175.722	200.56	152.05	444	173.2647706	CS
26	12.645	7.38221729231	171.29	200.56	143.463	878	162.17252066	CS
52	-61.548	-25.0722045926	245.483	264.4	143.463	604	175.48726448	CS
156	73.285	66.2313601446	110.65	264.4	82	607	157.18035003	CS
260	0	0	0	193.895	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PFTIPuradyn Filter Technologies Inc (CE)	$ 0.0025 (249,900.00%)	400
ONCIOn4 Communications Inc (PK)	$ 0.0001 (9,900.00%)	1.05M
IMTLImage Protect Inc (PK)	$ 0.0001 (9,900.00%)	10k
BTAEFBeta Energy Corporation (CE)	$ 0.0001 (9,900.00%)	188
HLTHQCue Health Inc (CE)	$ 0.0001 (9,900.00%)	3.9k
TLGNEver Harvest International Group Inc (CE)	$ 0.000001 (-99.67%)	4.16k
COUVCorporate Universe Inc (CE)	$ 0.0002 (-99.50%)	9.9k
REFGMedical Cannabis Payment Solutions (CE)	$ 0.000001 (-99.00%)	12.5k
VAXXVaxxinity Inc (CE)	$ 0.001 (-98.89%)	7.8k
SEEKTheDirectory com Inc (CE)	$ 0.000001 (-98.51%)	500k
VTXBVortex Brands Company (PK)	$ 0.0005 (25.00%)	352.06M
EARIEntertainment Arts Research Inc (PK)	$ 0.00015 (-50.00%)	248.83M
NAFSNorth America Frac Sand Inc (PK)	$ 0.0003 (20.00%)	205.91M
KGKGKona Gold Beverage Inc (PK)	$ 0.0004 (-20.00%)	154.79M
SNWRSanwire Corporation (PK)	$ 0.00075 (25.00%)	101.12M